Ccr4 Mutations Associated With Superior Outcome Of Adult T-Cell Leukemia/Lymphoma Under Mogamulizumab Treatment

Yuma Sakamoto,Takashi Ishida,Ayako Masaki,Takayuki Murase,Kentaro Yonekura,Yukie Tashiro,Masahito Tokunaga,Atae Utsunomiya,Asahi Ito,Shigeru Kusumoto,Shinsuke Iida,Ryuzo Ueda,Hiroshi Inagaki

BLOOD（2018）

引用 74|浏览2

暂无评分

摘要

TO THE EDITOR:Adult T-cell leukemia/lymphoma (ATL) is caused by human T-cell lymphotropic virus type 1.[1][1][⇓][2]-[3][3] Patients, especially those with an aggressive variant (acute, lymphoma, and unfavorable chronic subtypes),[4][4],[5][5] have an extremely poor prognosis.[1][1][⇓][2][⇓][

查看译文

关键词

ccr4 mutations,mogamulizumab treatment,leukemia/lymphoma,t-cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要